Jeffrey Leiden

Jeffrey Leiden
Jeffrey Leiden
Born	Glencoe, Illinois
Nationality	American
Alma mater	University of Chicago
Occupation(s)	Executive Chairman, Vertex Pharmaceuticals
Organizations	Clarus Ventures; Abbott Labs; Harvard School of Public Health and Medical School; Cardiogene; University of Chicago; Howard Hughes Medical Institute, University of Michigan;
Board member of	National Academy of Medicine; American Academy of Arts and Sciences; American Society for Clinical Investigation; Association of American Physicians; Harvard Medical School; Massachusetts Mutual Life Insurance Company; Massachusetts’s Governor’s Digital Healthcare Council; Governor’s STEM Advisory Council;
Awards	Ernst and Young Entrepreneur of the Year in Life Sciences (2017); Henri A. Termeer Innovative Leadership Award (2018); Academy of Distinguished Bostonians (2018); New Englander of the Year;
Website	Jeffrey Leiden

Jeffrey Leiden is an American physician, scientist and businessman who is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts.^[1] He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020.^[2]^[3]

^ Joe Carlson (December 16, 2011). "Vertex names Leiden incoming CEO". Modern Healthcare.
^ "Jeffrey Leiden M.D., Ph.D. and Dennis Winger Join Vertex Pharmaceuticals Incorporated's Board of Directors". Biospace. July 8, 2009.
^ "Jeffrey "Jeff" Leiden Chairman/President/CEO, Vertex Pharmaceuticals Inc". Bloomberg L.P. Retrieved May 12, 2018.

[1] Joe Carlson (December 16, 2011). "Vertex names Leiden incoming CEO". Modern Healthcare.

[2] "Jeffrey Leiden M.D., Ph.D. and Dennis Winger Join Vertex Pharmaceuticals Incorporated's Board of Directors". Biospace. July 8, 2009.

[3] "Jeffrey "Jeff" Leiden Chairman/President/CEO, Vertex Pharmaceuticals Inc". Bloomberg L.P. Retrieved May 12, 2018.

[1]

[2]

[3]